SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-005179
Filing Date
2018-04-30
Accepted
2018-04-30 16:22:50
Documents
90
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2017_biondvaxpharma.htm 20-F 2383385
2 ARTICLES OF ASSOCIATION OF BIONDVAX PHARMACEUTICALS LTD f20f2017ex1-1_biondvax.htm EX-1.1 499728
3 LEASE AGREEMENT DATED JULY 10, 2017 BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND UN f20f2017ex4-19_biondvax.htm EX-4.19 254295
4 CERTIFICATION f20f2017ex12-1_biondvax.htm EX-12.1 11757
5 CERTIFICATION f20f2017ex12-2_biondvax.htm EX-12.2 11612
6 CERTIFICATION f20f2017ex13-1_biondvax.htm EX-13.1 3973
7 CERTIFICATION f20f2017ex13-2_biondvax.htm EX-13.2 3838
8 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M f20f2017ex15-1_biondvax.htm EX-15.1 2297
9 GRAPHIC image_01.jpg GRAPHIC 63855
10 GRAPHIC image_02.jpg GRAPHIC 62952
11 GRAPHIC image_03.jpg GRAPHIC 45812
12 GRAPHIC img_001.jpg GRAPHIC 8342
  Complete submission text file 0001213900-18-005179.txt   8803685

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE bvxv-20171231.xml EX-101.INS 1659282
14 XBRL SCHEMA FILE bvxv-20171231.xsd EX-101.SCH 79141
15 XBRL CALCULATION FILE bvxv-20171231_cal.xml EX-101.CAL 37315
16 XBRL DEFINITION FILE bvxv-20171231_def.xml EX-101.DEF 128471
17 XBRL LABEL FILE bvxv-20171231_lab.xml EX-101.LAB 441146
18 XBRL PRESENTATION FILE bvxv-20171231_pre.xml EX-101.PRE 294780
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 20-F | Act: 34 | File No.: 001-37353 | Film No.: 18790117
SIC: 2836 Biological Products, (No Diagnostic Substances)